Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 20:00
Biogen Total Liabilities (Quarterly) : 13.24B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.24B |
| March 31, 2026 | 10.83B |
| December 31, 2025 | 11.18B |
| September 30, 2025 | 11.00B |
| June 30, 2025 | 10.70B |
| March 31, 2025 | 11.05B |
| December 31, 2024 | 11.33B |
| September 30, 2024 | 11.95B |
| June 30, 2024 | 10.92B |
| March 31, 2024 | 11.35B |
| December 31, 2023 | 12.05B |
| September 30, 2023 | 13.71B |
| June 30, 2023 | 10.70B |
| March 31, 2023 | 10.81B |
| December 31, 2022 | 11.17B |
| September 30, 2022 | 12.09B |
| June 30, 2022 | 13.22B |
| March 31, 2022 | 12.39B |
| December 31, 2021 | 12.92B |
| September 30, 2021 | 12.92B |
| June 30, 2021 | 13.26B |
| March 31, 2021 | 13.19B |
| December 31, 2020 | 13.93B |
| September 30, 2020 | 14.19B |
| June 30, 2020 | 14.22B |
| Date | Value |
|---|---|
| March 31, 2020 | 13.58B |
| December 31, 2019 | 13.90B |
| September 30, 2019 | 13.49B |
| June 30, 2019 | 13.34B |
| March 31, 2019 | 12.62B |
| December 31, 2018 | 12.26B |
| September 30, 2018 | 11.73B |
| June 30, 2018 | 11.70B |
| March 31, 2018 | 12.05B |
| December 31, 2017 | 11.05B |
| September 30, 2017 | 10.22B |
| June 30, 2017 | 10.19B |
| March 31, 2017 | 9.728B |
| December 31, 2016 | 10.75B |
| September 30, 2016 | 9.990B |
| June 30, 2016 | 10.11B |
| March 31, 2016 | 10.35B |
| December 31, 2015 | 10.13B |
| September 30, 2015 | 10.16B |
| June 30, 2015 | 4.186B |
| March 31, 2015 | 3.550B |
| December 31, 2014 | 3.503B |
| September 30, 2014 | 3.273B |
| June 30, 2014 | 3.353B |
| March 31, 2014 | 3.089B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.555B |
| AbbVie, Inc. | 141.00B |
| Gilead Sciences, Inc. | 37.62B |
| Vertex Pharmaceuticals, Inc. | 7.175B |
| Amgen, Inc. | 83.95B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.09B |
| Shareholders Equity (Quarterly) | 18.85B |
| Debt to Equity Ratio | 0.4433 |
| Current Ratio | 1.865 |
| Net Debt Paydown Yield | -1.09% |